EQUILLIUM, INC.

Analyst Reco. Equillium, Inc.

Equities

EQ

US29446K1060

Market Closed - Nasdaq Other stock markets 03:59:42 2024-05-28 pm EDT			5-day change	1st Jan Change
1.46 ^USD	+4.29%		-5.81%	+101.94%

May. 14	Equillium, Inc. Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease	CI
May. 09	Earnings Flash (EQ) EQUILLIUM Reports Q1 Revenue $10.7M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

H.C. Wainwright Adjusts Price Target on Equillium to $5 From $4, Keeps Buy Rating	Apr. 02	MT
HC Wainwright Adjusts Price Target on Equillium to $4 From $4.50, Keeps Buy Rating	Dec. 26	MT
HC Wainwright Adjusts Equillium's Price Target to $4.50 From $5.50, Maintains Buy Rating	Nov. 13	MT
Stifel Adjusts Price Target on Equillium to $7 From $12, Maintains Buy Rating	23-03-24	MT
SVB Securities Lowers Equillium's Price Target to $7 From $12, Maintains Outperform Rating	23-02-08	MT
Cantor Fitzgerald Adjusts Price Target for Equillium to $4 From $14, Maintains Overweight Rating	22-10-14	MT
HC Wainwright Adjusts Equillium's Price Target to $20 from $15, Maintains Buy Rating	22-09-27	MT
HC Wainwright Adjusts Equillium's Price Target to $15 From $12, Reiterates Buy Rating	22-03-24	MT
SVB Leerink Adjusts Equillium Price Target to $14 From $18, Outperform Rating Kept	22-01-05	MT
EQUILLIUM : Cantor Fitzgerald Starts Equillium at Outperform with $14 Price Target	21-09-16	MT
EQUILLIUM : JonesTrading Starts Equillium at Buy With $14 Price Target	21-03-03	MT
EQUILLIUM : HC Wainwright Adjusts Equillium's Price Target to $12 from $22, Keeps Buy Rating	20-11-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer